Glaxo recalls hypertension drug made at Novartis plant (Reuters)

Reuters – GlaxoSmithKline has recalled 394,230 bottles of its DynaCirc CR hypertension drug from the U.S. market after the manufacturer, Novartis, reported inconsistent packaging practices.